Trial intelligence / Profile preview

ESP vs ESP+SAP Block for Post-operative Pain in Thoracic Surgery

NCT04349774Phase 4Withdrawn

Start
Oct 2022
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in postoperative pain. Planned start Oct 2022; status: withdrawn.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04349774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04349774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call